AIHA Job Board    Marketplace
About Us      Blog      Career Center      Education       Membership      Resources
We enable professionals to promote responsible design, development, and management of products throughout their life cycle.


Endocrine Disruptor Testing Upgrades from EU: Stewardship and Substitution Implications

The European Commission issued recommendations in 2018 expanding testing guidelines to address endocrine endpoints not analyzed in current standardized tests. Additionally, the EU designation of products as having endocrine disrupting properties has now progressed to formal listings as Substances of Very High Concern, despite ongoing challenges to the criteria defining this hazard. For product stewards, this designation regarding products or ingredients creates business implications due to public perception about this hazard and the carry-over impacts for GHS and other country markets once the EU designates a substance an endocrine disruptor. This session will provide an update on pressures for costly additional testing and a team-based case study exercise will be used.

Presenter(s): Robert DeMott, Principal Toxicologist, Ramboll
Robert Skoglund, Director, Product Stewardship and Regulatory Affairs, Covestro

Presentation Date: 9/28/2018

Contact Hour(s): 1.0

Your Price: $24.95


AIHA footer

AIHA®Product Stewardship Society
3141 Fairview Park Dr.
Suite 777
Falls Church, VA 22042

Phone +1 703-849-8888

© AIHA®Product Stewardship Society

AIHA's Twitter AIHA's Facebook AIHA's LinkedIn